Skip to main content
Premium Trial:

Request an Annual Quote

EU to Fund 'Omics Studies for Screening AIDS Drug Candidates

NEW YORK (GenomeWeb News) — The European Commission will spend €3 million ($3.8 million) to fund AIDS research studies that will use or develop genomics and proteomics technologies, among others, aimed at developing new HIV/AIDS treatments.

The project, which is funded under the Seventh Framework program, will support studies to develop assays and drug screening technologies, as well as research on early drug candidates with acceptable toxicity profiles.

Other research could include elucidation of 3D structures of validated targets and rational drug design guided by molecular modeling and docking of inhibitors, and validation and exploitation of the HIV-susceptible transgenic rat models to allow in vivo evaluation of novel drug candidates from the HIV-ACE program.

The project will start March 1 and run through February 2011.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.